Pre-conference program provided recommendations for oncology pharmacy management strategies.
During the last two decades, managed care organizations (MCOs) have spent a considerable amount of time and resources managing prescription drug costs for large chronic disease categories.
Utilizing the management of multiple myeloma as an example, the pre-conference program, entitled “The Evolving Oncology Pharmacy Paradigm: Emerging Strategies for Managed Care Professionals,” recommended emerging oncology pharmacy management strategies and methods for managed care professionals to implement within their current setting as well as extrapolate to other types of cancer as needed.
This program included a distinguished panel of thought leaders such as David H. Vesole, MD, PhD, Hackensack University Medical Center; David G. Frame, PharmD, University of Michigan Health System; C. Daniel Mullins, PhD, University of Maryland School of Pharmacy; and Jeffrey D. Dunn, PharmD, MBA, SelectHealth.
Dr. Vesole explained the use of decision-support tools that utilize evidence-based treatment management plans for patients with multiple myeloma in a managed care setting. Dr. Frame described managed care strategies and methods, comparing and contrasting oncology versus traditional pharmacy management for patients with chronic illnesses. Dr. Mulllins identified techniques for MCOs to determine the cost-effectiveness and survival benefits of multiple myeloma therapies. Finally, Dr. Dunn explained emerging programs and methods that MCOs can implement to improve overall oncology patient outcomes.
Because managed care leaders have identified oncology drugs and biologics as priority areas for managing costs, further discussion is crucial to develop and implement new strategies, coordinate oncology care through case management, educate patients about treatment with current and emerging cancer drugs, and collaborate effectively with specialty pharmacy management.
For more information about this program, please visit www.amcp.org.
The Pivotal Role of Payers in Improving Health Equity, Maternal Health Care in the US
March 26th 2024A presentation at the Greater Philadelphia Business Coalition on Health's 2024 Women’s Health Summit discussed how payers, including employers and public entities, can strategically influence health care purchasing to prioritize maternal health and equity.
Read More
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Dupilumab Considered Safe, Effective Treatment for Adolescent, Adult Patients With AD
March 20th 2024These posters both used the GLOBOSTAD study, which demonstrated through patient and physician assessments that dupilumab is a safe and effective treatment for adolescent and adult patients with atopic dermatitis (AD).
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Racial Variations in Cardiovascular Outcomes Found in Hidradenitis Suppurativa Study
March 19th 2024Based on the findings, investigators acknowledged the critical need to consider racial differences when assessing patients with hidradenitis suppurativa. Health care providers should be vigilant in addressing cardiovascular risk factors in this population, recognizing and addressing racial disparities that may impact disease management.
Read More